WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010114801) ORAL FORMULATIONS OF DIPHENYLSULFONAMIDE ENDOTHELIN AND ANGIOTENSIN II RECEPTOR AGONISTS TO TREAT ELEVATED BLOOD PRESSURE AND DIABETIC NEPHROPATHY
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2010/114801 International Application No.: PCT/US2010/029093
Publication Date: 07.10.2010 International Filing Date: 29.03.2010
IPC:
A61K 31/422 (2006.01) ,A61P 9/12 (2006.01)
Applicants: ZHANG, Jinkun[US/US]; US (UsOnly)
DZIEWANOWSKA, Zofia, E.[US/US]; US (UsOnly)
BELDER, Rene[US/US]; US (UsOnly)
HENDERSON, Ian[US/US]; US (UsOnly)
BOGARDUS, Joseph, B.[US/US]; US (UsOnly)
ZHANG, Zhaoying[US/US]; US (UsOnly)
LIGAND PHARMACEUTICALS INC.[US/US]; 11085 North Torrey Pines Road Suite 300 San Diego, CA 92037, US (AllExceptUS)
Inventors: ZHANG, Jinkun; US
DZIEWANOWSKA, Zofia, E.; US
BELDER, Rene; US
HENDERSON, Ian; US
BOGARDUS, Joseph, B.; US
ZHANG, Zhaoying; US
Agent: MALLON, Joseph, J.; Knobbe Martens Olson & Bear LLP 2040 Main Street 14th Floor Irvine, CA 92614, US
Priority Data:
61/165,41931.03.2009US
61/165,44731.03.2009US
Title (EN) ORAL FORMULATIONS OF DIPHENYLSULFONAMIDE ENDOTHELIN AND ANGIOTENSIN II RECEPTOR AGONISTS TO TREAT ELEVATED BLOOD PRESSURE AND DIABETIC NEPHROPATHY
(FR) FORMULATION ORALE D'AGONISTES DES RÉCEPTEURS DE L'ENDOTHÉLINE ET DE L'ANGIOTENSINE II À BASE DE DIPHÉNYLSULFONAMIDE POUR TRAITER UNE PRESSION SANGUINE ÉLEVÉE ET UNE NÉPHROPATHIE DIABÉTIQUE
Abstract:
(EN) Methods of administering and pharmaceutical compositions of a biphenyl sulfonamide compound which is a dual angiotensin and endothelin receptor antagonist are disclosed for treating diseases.
(FR) L'invention porte sur des procédés d'administration et sur des compositions pharmaceutiques d'un composé diphénylsulfonamide qui est un antagoniste double des récepteurs de l'angiotensine et de l'endothéline pour le traitement de maladies.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)